期刊文献+

活血化瘀法治疗老年恶性肿瘤伴发下肢静脉血栓患者疗效分析 被引量:4

Exploratory treatment of elderly cancer patients with lower limb vein thrombosis
下载PDF
导出
摘要 目的:研究活血化瘀疗法对老年恶性肿瘤患者伴发下肢静脉血栓的疗效。方法:42例患者分为对照组(20例)与观察组(22例),对照组进行一般治疗;观察组在一般治疗基础上加用活血化瘀治疗,银杏达莫注射液20mL加入0.9%生理盐水250mL静脉滴注,2次/d,2周为1个疗程。比较两组血小板(PLT)、凝血酶原时间(PT)、D-二聚体(D-Di)水平与小腿周径变化。结果:观察组总有效率(81.82%)明显高于对照组(70.00%)(P<0.05);治疗后观察组小腿周径变化与D-Di水平变化均明显优于对照组(P<0.05);两组PT与PLT无明显差异(P>0.05)。结论:活血化瘀疗法对老年恶性肿瘤伴发下肢静脉血栓患者疗效肯定,安全性良好,值得进一步研究。 Objective: To investigate the effect of the therapy of promoting blood circulation on elderly cancer patients with lower limb vein thrombosis.Methods: Forty-two patients were divided into two groups.Twenty patients in the control group were treated with routine treatment and twenty-two patients in the treatment group were treated with both routine treatment and therapy of promoting blood circulation(Yinxingdamo injection 20ml added into 250ml 0.9% saline for intravenous infusion,once daily).Results: The overall response rate of the treatment group is 81.82%,while the control group 70.00%.The changes of calf perimeter and D-Di contents of the treatment group are significantly better than control group.The prothrombin time and platelets contents have no significant change.Conclusions:The therapy of promoting blood circulation has positive effect on elderly cancer patients with lower limb vein thrombosis and is worthy of further study.
作者 张清 杨卉
出处 《海南医学院学报》 CAS 2011年第10期1329-1332,共4页 Journal of Hainan Medical University
基金 海南医学院科研基金资助学报项目(0020110359)~~
关键词 恶性肿瘤 下肢静脉血栓 活血化瘀 银杏达莫 Cancer Lower limb vein thrombosis Promoting blood circulation Yinxingdamo injection
  • 相关文献

参考文献6

  • 1Letai A, Kuter D. Cancer, coagulation and anticoagulation[J]. The Oncologist, 1999,4:443. 被引量:1
  • 2Wagman LD, Baird MF, Bennet CL, et al. Venous thromboembolic disease. Clinical practice guidelines in oncology[J]. J Natl Compr Cane Netw, 2006,4(9) :838- 869. 被引量:1
  • 3深静脉血栓形成的诊断和治疗指南[J].中华普通外科杂志,2008,23(3):235-238. 被引量:266
  • 4孙建民.下肢深静脉血栓形成.见:兰锡纯.心脏血管外科学[M].北京:人民卫生出版社,2002:1270. 被引量:1
  • 5Mousa SA, Petersen LJ. Anti-cancer properties of lowmolecular-weight heparin: Preclinical evidence [ J ]. Thromb Haemost, 2009,102(2) :258-267. 被引量:1
  • 6Lee KW, Bang SM, Kim S, et al. The incidence, risk factors and prognostic implications of venous thromboembolism in patients with gastric cancer[J]. J Thromb Haemos,2009,8(3) :540-547. 被引量:1

共引文献265

同被引文献72

  • 1吴庆华.盆腔和腹部手术后抗凝药物的应用[J].中华外科杂志,2006,44(19):1297-1299. 被引量:8
  • 2陈文慧,张予辉,王辰.恶性肿瘤与血液系统[J].国际呼吸杂志,2007,27(8):588-590. 被引量:11
  • 3郭丹杰,胡大一.美国临床肿瘤学会癌症患者静脉血栓栓塞防治指南解读[C].第十届中国南方国际心血管病学术会议论文集,2008:550-553. 被引量:3
  • 4McCaffrey R, Bishop M, Adonis - Rizzo M, et al. Development and testing of a VTE risk assessment tool: providing evidence of validity and reliability [ J ]. Worldviews Evid Based Nuts, 2007, 4 (1): 14-20. 被引量:1
  • 5Debourdeau P, Beckers M, Gerome P, et al. How to improve the implementation of guidelines on cancer - related thrombosis [J]. Expert Rev Anticancer Ther, 2011, 11 (3) : 473 - 483. 被引量:1
  • 6Wun T, White RH. Epidemiology of cancer - related venous thromboembolism [ J ]. Best Praet Res Clin Haematol, 2009, 22 (1): 9 -23. 被引量:1
  • 7Labropoulos N, Jen J, Jen H, et al. Recurrent deep vein thrombosis : long - term incidence and natural history [ J ] . Tassiopoulos AK Ann Surg, 2010, 251 (4): 749-753. 被引量:1
  • 8Mili FD, Hooper WC, Lally C, et al. The impact of co - morbid conditions on family history of venous thromboembolism in Whites and Blacks [J].Thromb Res, 2011, 127 (4) : 309 -316. 被引量:1
  • 9Rodriguez AO, Gonik AM, Zhou. H, et al. Venous thromboembolism in uterine cancer [ J ]. Int J Gynecol Cancer, 2011, 21 (5): 870- 876. 被引量:1
  • 10Kessler CM. The link between cancer and venous thromboembolism [ J ]. Am J Clin Oncol, 2009, 32 (4): 53-57. 被引量:1

引证文献4

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部